Your chances of a migraine increase with hotter temperatures
Research by Dr. Vincent Martin is featured in national and international media
A change in weather is one of the most common trigger factors for migraine. Hotter temperatures increase the chance of a migraine attack, according to research led by Vincent Martin, MD, director of the Headache and Facial Pain Center at UC’s Gardner Neuroscience Institute.
Martin, also a professor in the UC College of Medicine, spoke with Cincinnati’s Fox 19 News about his latest study findings which looked at use of Fremanezumab and whether it could prevent headaches caused by temperature increases. Produced by Teva Pharmaceuticals USA, Fremanezumab is sold under the brand name AJOVY®, administered by injection under the skin to treat migraines.
A research team led by Martin cross-referenced 71,030 daily diary records of 660 migraine patients with regional weather data and found that for every temperature increase of 10 degrees Fahrenheit daily, there was a 6% increase in occurrence of any headache. However, during the time periods of Fremanezumab treatment the association completely disappeared.
Record high temperatures across much of the Midwest and Northeast regions of the country has increased dialogue about health ailments associated with the heat. Martin’s findings were reported on more than 200 media outlets including CBS News, The Atlanta Journal Constitution, The Miami Herald and internationally in publications such as Greece’s Tempo 24, Argentina’s Infobae, Italy’s Agenzia Italia, Mexico’s El Cuarto Poder , Venezuela’s Noticias Venevision and Indonesia’s Suara Merdeka.
Read about the research findings from Vincent Martin, MD, online.
Learn more about migraines and hotter temperatures on CBS News
Featured top image is courtesy of Istock.
Related Stories
Are women more susceptible to PTSD?
November 10, 2026
UC neuroscientist James Herman, PhD, and colleagues report that a specific stress hormone pattern in female animal models may signal vulnerability to PTSD, offering a potential biomarker to help explain why women are diagnosed at roughly twice the rate of men.
Christy K. Holland, PhD, named UC's 2026-27 Big 12 Faculty of the Year
November 9, 2026
Christy K. Holland, PhD, has been named the University of Cincinnati's 2026-27 Big 12 Faculty of the Year for her internationally recognized research in biomedical ultrasound and cardiovascular innovation.
Why so much hype around the new Grand Theft Auto?
November 6, 2026
UC experts from DAAP's game and animation program to a doctor at the Lindner Center of HOPE discuss the pros and cons surrounding the upcoming billion-dollar game Grand Theft Auto VI.